EASL Roundup: Path to 'Cure' in Hep B? Low-Carb, High-Fat Diet for NAFLD With T2D Noteworthy research from the European Association for the Study of the Liver annual meeting Jun 29, 2022
'A New Hope' for Rare, Deadly Liver Disease Small fazirsiran trial sees fibrosis regressions for liver disease associated with AAT deficiency Jun 28, 2022
Mixed Bag for Semaglutide in NASH-Related Compensated Cirrhosis Randomized trial showed improvements in cardiometabolic markers, but not liver fibrosis Jun 27, 2022
Liver Cirrhosis Tied to Elevated Risk for Stroke 37% higher risk observed in large German study Jun 25, 2022
Bulevirtide's Effect Sustained in Difficult-to-Treat Hepatitis D Nearly half of patients at week 48 had virological and biochemical response Jun 25, 2022
Early Liver Disease Detection Linked to Subsequent Lifestyle Improvements Danish study shows fibrosis screening associated with improved diet, alcohol use, and exercise Jun 24, 2022
Liver Preserved for 3 Days With Machine Perfusion Successfully Transplanted Patient healthy and leading normal life at 1 year Jun 01, 2022
POSE 2.0 Linked to Improved Outcomes in NAFLD Patients With Obesity Steatosis resolved in 53% of patients who underwent this minimally invasive procedure May 24, 2022
Medication for Drinking Addiction May Thwart Liver Disease Alcohol-related liver disease 63% lower for those taking medical addiction therapy May 20, 2022
MELD Scoring for Liver Transplants in Need of Sex Adjustment, Study Says Researchers find "pervasive sex differences" in sodium-adjusted MELD scoring system May 18, 2022
Investigational Liver Drug Also Effective in Patients With Hypothyroidism "This is yet another reason endocrinologists should get involved in fatty liver disease" May 15, 2022
Fatigue Tied to Worse Outcomes in Patients With NASH Scores indicating worse fatigue associated with liver-related and decompensation events May 09, 2022
Unusual Hepatitis Spreads; IBD and Erectile Dysfunction; Can PFAS Harm Livers? News and commentary from the world of gastroenterology and hepatology Apr 28, 2022
PPIs Linked to Better Survival for One Group With Cirrhosis Large VA study shows potential benefit for one group, risk for the rest Apr 11, 2022
GLP-1 Receptor Agonists: How Safe Are They for the Gallbladder? Link with gallbladder, biliary diseases could be due to weight loss associated with class of drug Mar 28, 2022
In Cirrhosis, Less Activity Equals Worse Outcomes The lower the daily step count, the higher the risk of hospitalization and death Mar 23, 2022
Rinvoq Approved for UC; HCC Combo Flops; Disney Grants Pass to IBS Patient News and commentary from the world of gastroenterology and hepatology Mar 17, 2022
Robotic Hepatectomy Shows Benefits Over Laparoscopic Surgery Shorter hospital stay, similar perioperative outcomes in matched analysis Mar 10, 2022
Kids With IBD Need Close Monitoring as They Grow Up Meta-analysis confirms: substantially increased cancer risk in adulthood Mar 02, 2022
SubQ Infliximab Works for IBD; FDA Clears Complex Colonoscopy Tool; IBS & Diet News and commentary from the world of gastroenterology and hepatology Feb 18, 2022
Recurrent Autoimmune Hepatitis Post-Liver Transplant: What Are the Risks? Probability of recurrent disease more than doubled from 5 to 20 years later Feb 09, 2022
Potential New First-Line Options for Unresectable Hepatocellular Carcinoma Tremelimumab-durvalumab improves OS, single-agent durvalumab non-inferior to sorafenib Jan 22, 2022
Fatty Liver Disease a Long-COVID Symptom After Severe Cases? In Italian study, over half had metabolic dysfunction-associated fatty liver disease Jan 11, 2022
Is Weight Protective for NAFLD Patients Undergoing Transplant? UNOS data showed differences in waitlist removal, all-cause mortality based on obesity status Nov 18, 2021
Hepatology Not Immune to Workplace Discrimination Women, racial/ethnic minorities most likely to experience discriminatory behavior Nov 17, 2021
Need for Liver Transplants Rising Sharply in Seniors Post-transplant mortality still higher versus younger patients, but improving over time Nov 17, 2021
How Do Patients With Cirrhosis Respond to the COVID Vaccine? Italian researchers examine data in this understudied subset of patients Nov 16, 2021
Blood-Based Biomarkers Prove Mettle in Liver Disease Diagnosis Data part of initiative to qualify biomarkers to help diagnose fibrosis or NASH Nov 15, 2021
FMT Benefits Last a Few Years in Severe Alcoholic Hepatitis Patients More research needed to determine impact on clinical outcomes versus standard of care Nov 14, 2021
Simvastatin-Treated Liver Donors May Aid Transplant Patient Outcomes Improved graft survival versus placebo in small randomized trial Nov 14, 2021
How Did the COVID Pandemic Affect Liver Transplant Outcomes? There was an impact on patient survival rates, but researcher acknowledges several confounders Nov 13, 2021
NASH Patients Are Entitled to a 'Bill of Rights' Advocacy group encourages a "partnership" between clinicians and patients Nov 12, 2021
Injectable PH1 Therapy Also Effective in Advanced CKD Trial looked at patients with stages 3B through 5 chronic kidney disease Nov 07, 2021
Advanced Fibrosis Tied to Most Severe Outcomes in NAFLD Study found higher risk of liver decompensation, death in those with bridging fibrosis, cirrhosis Oct 20, 2021
Pan-PPAR Agonist 'Promising' for NASH Patients But experts expressed concern over potential GI side effects Oct 20, 2021
A Cup of Joe to Thwart Liver Fibrosis? How About Four Study finds protective benefit with high consumption, though not for fatty liver disease Oct 08, 2021
High-Dose HBV Revaccination Better Protects HIV Patients Phase III trial saw more and longer-lasting responses with double the dose Aug 24, 2021
Can Liver Donor Biomarker Predict Liver Transplant Rejection? Findings could support a patient-centered approach to liver transplantation, expert says Aug 23, 2021
Liver Transplant Sex Disparities Vanish With Living-Donor Access Women who qualified for deceased donor organs had significantly worse MELD scores Aug 18, 2021
Herbal Weight-Loss Supplement Tied to Severe Liver Damage Garcinia cambogia and green tea led to clinically indistinguishable liver injury Aug 17, 2021
